Low vitamin D levels consistently show up alongside higher blood pressure in population studies, but whether the deficiency actually drives the rise in pressure remains one of the more frustrating open questions in cardiovascular research. Large observational studies have found that people with the lowest vitamin D levels face roughly two to three times the risk of developing hypertension compared to those with adequate levels. Yet when researchers run clinical trials and give people vitamin D supplements, blood pressure barely budges. That disconnect hints at a relationship that is real but far more tangled than a simple cause-and-effect story.
What Population Studies Actually Show
The observational signal is strong enough that it cannot be waved away. A prospective study following over 1,800 men and women with measured blood levels of 25-hydroxyvitamin D (the standard marker of vitamin D status) found that those whose levels fell below 15 ng/mL had a pooled relative risk of developing hypertension roughly three times that of people above 30 ng/mL. When the researchers extended their analysis to larger cohorts using predicted vitamin D levels, the trend held across more than 100,000 participants tracked for up to 18 years.1PubMed. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension A separate meta-analysis pooling seven prospective studies with over 53,000 participants confirmed the association, finding that vitamin D deficiency was linked to about a 24% higher risk of incident hypertension after adjusting for confounders.2PLOS ONE. Vitamin D and hypertension: Prospective study and meta-analysis
These are not small, cherry-picked datasets. The consistency across different populations and study designs is what keeps the hypothesis alive. But observational studies can only show that two things travel together. People with low vitamin D also tend to be older, heavier, less physically active, and more likely to have chronic kidney disease, all of which independently raise blood pressure. The question is whether vitamin D is part of the causal chain or just along for the ride.
How Vitamin D Could Plausibly Raise Blood Pressure
There are at least three biologically plausible pathways linking vitamin D deficiency to elevated blood pressure, and each has been demonstrated in laboratory or animal studies.
The most studied pathway involves the renin-angiotensin system, the hormonal cascade that regulates blood pressure by controlling how tightly blood vessels constrict and how much sodium the kidneys retain. The active form of vitamin D directly suppresses renin, the enzyme that kicks off this cascade. In animal models, knocking out the vitamin D receptor led to overproduction of renin and elevated blood pressure, an effect that was independent of calcium metabolism.3JCI Insight. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system When vitamin D is scarce, the brake on this system loosens, and renin activity climbs.
A second pathway runs through the inner lining of blood vessels. Vitamin D helps endothelial cells produce nitric oxide, a molecule that relaxes vessel walls and keeps blood flowing smoothly. Deficiency reduces nitric oxide availability, stiffens arteries, and impairs what researchers call endothelial function, essentially the blood vessel’s ability to dilate on demand.4PubMed Central. Vitamin D and Endothelial Function In a study of over 500 healthy people, vitamin D levels were independently associated with multiple markers of arterial stiffness and vascular function even after accounting for cholesterol, inflammation, and medications. When a subset of participants with low vitamin D normalized their levels over six months, their mean arterial pressure dropped by about 4.6 mmHg.5PubMed Central. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans
A third, more recently described mechanism involves smooth muscle cells in vessel walls. Under inflammatory stress, these cells can shift from a stable, contractile state to a proliferative one that thickens and stiffens arteries. Vitamin D appears to counteract this shift, partly by dialing down a protein called PCSK9 in these cells and activating a protective enzyme called SIRT6. In mice, vitamin D supplementation before arterial injury reduced the resulting vessel thickening.6PubMed. Vitamin D attenuates PCSK9-driven phenotypic switch of vascular smooth muscle cells and neointimal hyperplasia via SIRT6 activation
Why Supplements Mostly Fail to Lower Blood Pressure
If the biology is so compelling, you would expect handing people vitamin D pills to bring their blood pressure down. That is not what the trial data shows. A large meta-analysis using individual patient data from thousands of trial participants found essentially zero effect on either systolic or diastolic blood pressure from vitamin D supplementation. The effect sizes were so small they were indistinguishable from noise.7PubMed Central. Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data A second, more recent meta-analysis of randomized controlled trials reached the same conclusion: no meaningful reduction in either systolic or diastolic pressure.8Preventing Chronic Disease. Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials
This null result has held up across meta-analysis after meta-analysis and is one of the most replicated negative findings in the vitamin D literature. It has led many cardiologists to conclude that supplementation, at least as tested so far, is not a useful blood pressure intervention for the general population.
The critical caveat is that most of these trials enrolled people who were not particularly deficient in vitamin D. When you look specifically at people who start out with genuinely low levels, the picture shifts. A New Zealand trial found that in participants who were deficient at baseline, a year of high-dose monthly vitamin D lowered central aortic systolic pressure by about 7.5 mmHg and improved several measures of arterial stiffness, while doing nothing in the overall sample.9PubMed Central. Effect of Monthly, High-Dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy A smaller double-blind trial in vitamin D-deficient patients with elevated blood pressure reported systolic pressure drops of about 6 mmHg compared to placebo.10PubMed. The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial A separate meta-analysis also found a small but statistically significant drop in diastolic pressure specifically in participants with pre-existing heart or metabolic disease.11Springer Link (European Journal of Epidemiology). Vitamin D and high blood pressure: causal association or epiphenomenon?
So the broad-strokes story is that giving vitamin D to people who already have enough does nothing for blood pressure, which makes biological sense. The more nuanced question, whether correcting true deficiency can modestly lower pressure, has positive signals but not yet the kind of large, definitive trial that would change clinical guidelines.
The Genetics Do Not Settle the Debate
One powerful way to test whether low vitamin D actually causes high blood pressure, rather than just accompanying it, uses a technique called Mendelian randomization. The idea is straightforward: certain gene variants make people naturally prone to lower vitamin D levels throughout their lives. If low vitamin D truly causes hypertension, people carrying those variants should have higher blood pressure, regardless of confounders like obesity or exercise.
The results are split. A large study using data from multiple consortia found that each 10% increase in genetically predicted vitamin D concentration was associated with a small drop in diastolic pressure and about an 8% lower odds of hypertension.12PubMed. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study But a more recent study from Norway’s HUNT population found no causal relationship at all between genetically determined vitamin D levels and blood pressure or hypertension risk.13Scientific Reports. Serum vitamin D, blood pressure and hypertension risk in the HUNT study using observational and Mendelian randomization approaches Population-specific differences, the particular gene variants chosen as instruments, and statistical power could all explain the disagreement. The genetic evidence leans weakly toward a real but small causal effect, with enough conflicting data that the question stays genuinely open.
Obesity Makes Everything Harder to Untangle
Obesity is a major confounder in any study linking vitamin D to blood pressure, because it strongly predicts both low vitamin D and high blood pressure through independent mechanisms. Fat tissue sequesters vitamin D, diluting circulating levels. At the same time, excess weight increases blood volume, stiffens arteries, and ramps up the renin-angiotensin system through its own pathways. Vitamin D deficiency is dramatically more common in people with obesity, and the proposed biological mechanisms overlap: both deficiency and excess fat can overstimulate the renin-angiotensin-aldosterone system and worsen insulin resistance.14Obesity Medicine. Vitamin D deficiency in obesity: Epidemiological evidence, biological mechanisms, and clinical considerations
This creates a statistical headache. In many observational studies, adjusting for body mass index weakens or eliminates the association between vitamin D and blood pressure. That does not prove vitamin D is irrelevant, but it does mean that some portion of what looks like a vitamin D effect could really be an obesity effect. Researchers who design future supplementation trials will likely need to enroll lean, deficient individuals to tease the two apart cleanly.
Sunlight, Skin Pigmentation, and Blood Pressure Disparities
Blood pressure tends to be higher during winter months, at higher latitudes, and in populations with darker skin. All of these factors also predict lower vitamin D levels, which has tempted researchers to draw a straight line from sun exposure to vitamin D to blood pressure. The reality is messier.
A large U.S. study called REGARDS found that solar radiation was inversely associated with systolic blood pressure, with roughly 3.5 mmHg lower pressure per standard-deviation increase in sun exposure after full adjustment. But adding vitamin D levels to the model did not weaken this association, suggesting that sunlight lowers blood pressure through pathways beyond vitamin D alone.15PubMed Central. Associations of Blood Pressure, Sunlight, and Vitamin D in Community-Dwelling Adults Ultraviolet light triggers the release of nitric oxide from skin stores, a mechanism entirely separate from the vitamin D pathway. So the geographic and seasonal patterns in blood pressure likely reflect multiple effects of UV exposure, not just vitamin D production.16PubMed. Ultraviolet light may contribute to geographic and racial blood pressure differences
That said, skin pigmentation does matter for both vitamin D status and vascular health. Darker skin requires more UV exposure to produce the same amount of vitamin D, and a study of healthy young adults found that greater skin pigmentation was associated with lower vitamin D levels and reduced microvascular endothelial function, independent of race or ethnicity.17PubMed Central. Skin pigmentation is negatively associated with circulating vitamin D concentration and cutaneous microvascular endothelial function This does not mean vitamin D deficiency fully explains the well-documented cardiovascular disparities between racial groups, but it suggests it may be one contributing factor among many, particularly for people with dark skin living in low-sunlight environments.18PubMed Central. Skin pigmentation and vitamin D-folate interactions in vascular function: an update
Vitamin D Deficiency and Preeclampsia
Pregnancy creates its own version of this question. Preeclampsia, a dangerous condition marked by sudden high blood pressure after the 20th week of pregnancy, has been repeatedly linked to low vitamin D. A nested case-control study found that a halving of early-pregnancy vitamin D concentration roughly doubled the odds of developing preeclampsia after adjusting for confounders.19The Journal of Clinical Endocrinology & Metabolism. Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia Multiple reviews have echoed this association, though most call for larger intervention trials before drawing firm conclusions about supplementation as prevention.20PubMed Central. Vitamin D Deficiency as a Risk Factor of Preeclampsia during Pregnancy
The biological plausibility is stronger here than in the general hypertension literature, because the placenta produces its own active vitamin D and has vitamin D receptors, and because preeclampsia involves exactly the kind of endothelial dysfunction and renin-angiotensin activation that vitamin D deficiency is known to promote. A study tracking vitamin D at multiple time points during pregnancy found that very low levels in the third trimester were associated with a significantly higher rate of preeclampsia, though the numbers were small.21Scientific Reports. Vitamin D deficiency during late pregnancy mediates placenta-associated complications For now, the evidence is strong enough to monitor and correct deficiency in pregnancy but not strong enough to call vitamin D supplementation a proven preeclampsia preventive.
Early Life Vitamin D and Childhood Blood Pressure
There is growing interest in whether vitamin D status at birth or in infancy shapes blood pressure trajectories years later. A study following children from birth through age 18 found that those with low vitamin D at birth had about a 38% higher odds of elevated systolic blood pressure during childhood and adolescence. Children who remained deficient from birth through early childhood faced roughly double the odds.22PubMed Central. Vitamin D Trajectories From Birth to Early Childhood and Elevated Systolic Blood Pressure During Childhood and Adolescence
More strikingly, cord blood vitamin D levels appear to modify the impact of maternal preeclampsia on a child’s later blood pressure. Among children born to mothers who had preeclampsia, those in the lowest quartile of cord blood vitamin D had systolic blood pressure percentiles about 10 points higher than children of non-preeclamptic mothers. In the highest vitamin D quartile, that gap disappeared entirely.23JAMA Network Open. Associations of Cord Blood Vitamin D and Preeclampsia With Offspring Blood Pressure in Childhood and Adolescence This dose-dependent interaction raises the possibility that adequate vitamin D at birth could buffer children against some of the lasting cardiovascular effects of a complicated pregnancy.
Vitamin D Receptor Gene Variants
Your response to vitamin D is not identical to everyone else’s, and part of that variation is genetic. The vitamin D receptor gene has several well-studied variants, and researchers have asked whether certain versions of this gene increase hypertension risk. A prospective study of men found that specific variants in the BsmI and FokI regions of the vitamin D receptor gene were associated with a 25% to 32% higher risk of developing hypertension.24PubMed Central. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men
A large updated meta-analysis and meta-regression, however, found the picture is less tidy across populations. The BsmI variant showed a consistent association with lower hypertension risk in people carrying two copies of the recessive allele. But for FokI, the association depended heavily on study quality, participant age, and sex, making it unreliable as a standalone marker.25PLoS ONE. Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression A study from Bangladesh found significantly higher prevalence of the FokI variant among hypertensive patients compared to controls, but the authors noted that population-specific genetics likely matter.26PubMed Central. Vitamin D deficiency and the vitamin D receptor (VDR) gene polymorphism rs2228570 (FokI) are associated with an increased susceptibility to hypertension among the Bangladeshi population The takeaway is that how efficiently your body uses vitamin D may matter as much as how much you have circulating, and that genetic background modulates whether deficiency translates into cardiovascular risk.
Kidney Disease and Parathyroid Hormone
The relationship between vitamin D and blood pressure gets more complicated once the kidneys are involved. The kidneys are responsible for converting vitamin D into its active form, and as kidney function declines, that conversion stalls. In chronic kidney disease, the resulting drop in active vitamin D contributes to elevated parathyroid hormone, systemic inflammation, and hypertension as part of a broader cascade of mineral and hormone disruption.27Best Practice & Research Clinical Endocrinology & Metabolism. Vitamin D in chronic kidney disease
Parathyroid hormone itself may play a mediating role. When vitamin D drops, parathyroid hormone rises, and parathyroid hormone has direct effects on calcium handling in blood vessels that could stiffen arteries and raise pressure. One study found a positive correlation between parathyroid hormone and blood pressure that persisted after adjustments, specifically in people who were vitamin D insufficient.28Nutrition. Parathyroid hormone has an important role in blood pressure regulation in vitamin D–insufficient individuals A Chinese population study saw a similar crude association, though it weakened after adjusting for body mass and other confounders.29PLoS ONE. Vitamin D, Parathyroid Hormone and Their Associations with Hypertension in a Chinese Population The broader point is that vitamin D deficiency rarely acts alone. It triggers secondary hormonal changes, particularly in parathyroid hormone, that may independently raise blood pressure.
When Too Much Vitamin D Raises Blood Pressure
In an ironic twist, excessive vitamin D can itself cause high blood pressure. Vitamin D toxicity, typically from taking very high supplemental doses over a long period, leads to dangerously elevated calcium levels in the blood. That excess calcium can constrict blood vessels and damage the kidneys, both of which drive blood pressure up. A case report described a one-year-old child who developed acute hypertension and severe hypercalcemia from vitamin D toxicity, an outcome initially masked by dehydration.30PubMed Central. An Unsuspected Pharmacological Vitamin D Toxicity in a Child and its Brief Review of Literature Toxicity is extremely rare at standard supplemental doses and essentially impossible from sun exposure alone, since the skin has a built-in mechanism to limit vitamin D production. But it is a reminder that more is not always better, and that chasing very high blood levels through megadoses can backfire in cardiovascular ways.